KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Amortization of Deferred Charges (2016 - 2025)

HCA Healthcare (HCA) has disclosed Amortization of Deferred Charges for 16 consecutive years, with $12.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Amortization of Deferred Charges rose 33.33% to $12.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $44.0 million, a 25.71% increase, with the full-year FY2025 number at $44.0 million, up 25.71% from a year prior.
  • Amortization of Deferred Charges was $12.0 million for Q4 2025 at HCA Healthcare, up from $7.0 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $14.0 million in Q2 2025 to a low of $6.0 million in Q2 2021.
  • A 5-year average of $8.5 million and a median of $8.0 million in 2021 define the central range for Amortization of Deferred Charges.
  • Peak YoY movement for Amortization of Deferred Charges: fell 25.0% in 2021, then soared 75.0% in 2025.
  • HCA Healthcare's Amortization of Deferred Charges stood at $6.0 million in 2021, then rose by 16.67% to $7.0 million in 2022, then grew by 28.57% to $9.0 million in 2023, then changed by 0.0% to $9.0 million in 2024, then skyrocketed by 33.33% to $12.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCA's Amortization of Deferred Charges are $12.0 million (Q4 2025), $7.0 million (Q3 2025), and $14.0 million (Q2 2025).